Fundraising Fox

/Companies

InspireMD

NASDAQ: NSPR

Miami, US · Delaware corporation · 1 known investors

Find your way into InspireMD

491 people in our graph share verified history with the InspireMD team — schools, employers, funds. One of them is your warm intro.

Maryse Bichlerunlockedknows Craig Shore · together at InspireMD (overlapped)

×2knows the team · via Trivascular

×3knows the team · via Nuvaira

×2knows the team · via Edwards Lifesciences

×2knows the team · via Johnson & Johnson

knows the team · via Surmodics, Inc.

InspireMD develops and commercializes medical devices for vascular intervention, including carotid stent systems and embolic protection systems sold through direct sales in the United States and via distributors in international markets.

Biotech Healthtech

Founders & leadership

PV

Patrick VertaExecutive Vice President Clinical and Medical Affairs2023–2025

PL

Pete Ligotti

Pete LigottiExecutive

ML

Mike LawlessChief Financial Officer

SG

Shane Gleason

Shane Gleason Chief Commercial Officer & General ManagerShane Gleason held leadership roles in clinical and commercial operations at medical device companies including TriVascular, Cordis, Abbott, and Nuvaira, where he oversaw sales team management, regulatory strategy, and product launches in vascular intervention and cardiac therapies.

MS

Marvin Slosman

Marvin Slosman Chief Executive OfficerMarvin Slosman is Chief Executive Officer of InspireMD, a medical device company commercializing vascular intervention products including carotid stent systems. He brings over 35 years of experience in medical device development, clinical and regulatory strategy, commercial launch, and capital raising across private and public companies.

AT

Andrea Tommasoli

Andrea TommasoliChief Operating Officer

AM

Alan MilinazzoExecutive

CS

Craig Shore Chief Financial Officer2010–2025He has served as Chief Financial Officer across operations in the United States and Israel, with experience raising over $150 million through various capital markets channels including IPOs, secondary offerings, and convertible debt.

JB

James BarryExecutive

Board

IB

Isaac BlechBoard director

PS

Paul StukeBoard director

RC

Raymond Cohen

Raymond Cohen Independent Director2025–2026Multi-exit CEO/Chairman at Star51 Capital

Investors · 1

OrbiMedlisted by OrbiMedNew York · $1M – $75M

How we know: OrbiMed's portfolio page · funding news · stocktitan.net · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$83.8M disclosed across 5 of 6 rounds · 2016–2025

▶$40.1MraisedAug 2025 · 18 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Raymond CohenDirector
Thomas J. KesterDirector
Scott R. WardDirector
Patrick VertaExecutive Officer
Kathryn ArnoldDirector
Pete LigottiExecutive Officer
Mike LawlessExecutive Officer
Shane GleasonExecutive Officer
Marvin SlosmanExecutive Officer, Director
Michael BermanDirector
Gary Roubin, M.D.Director
Andrea TommasoliExecutive Officer
Paul StukaDirector

Offering amount: $40.1M
Amount sold: $40.1M
Sales commissions: $2.4M
Placement agents: BofA Securities, Inc.
First sale: Jul 2025
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$42.2MraisedMay 2023 · 18 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Shane GleasonExecutive Officer
Thomas J. KesterDirector
Paul StukaDirector
Michael BermanDirector
Marvin SlosmanExecutive Officer, Director
Gary Roubin, M.D.Director
Craig ShoreExecutive Officer
Andrea TommasoliExecutive Officer
Kathryn ArnoldDirector

Offering amount: $42.2M
Amount sold: $42.2M
Sales commissions: $4.2M
Placement agents: Piper Sandler & Co., A.G.P./Alliance Global Partners, LifeSci Capital LLC
First sale: May 2023
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$750KraisedDec 2017 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Campbell RogersDirector
Paul StukaDirector
Thomas KesterDirector
James BarryExecutive Officer, Director
Michael BermanDirector
Craig ShoreExecutive Officer

Offering amount: $750K
Amount sold: $750K
Minimum investment: $750K
First sale: Dec 2017
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$182.4KraisedJun 2016 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Sol BarerDirector
Campbell RogersDirector
Isaac BlechDirector
James BarryExecutive Officer, Director
Craig ShoreExecutive Officer
Paul StukeDirector
Michael BermanDirector

Offering amount: $182.4K
Amount sold: $182.4K
First sale: Jun 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$609.5KraisedMar 2016 · 4 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Alan MilinazzoExecutive Officer, Director
Michael BermanDirector
Sol BarerDirector
Campbell RogersDirector
Isaac BlechDirector
James LoughlinDirector
Craig ShoreExecutive Officer
Paul StukeDirector
James BarryExecutive Officer, Director

Offering amount: $609.5K
Amount sold: $609.5K
Sales commissions: $48.8K
Placement agents: Dawson James Securities, Inc.
First sale: Mar 2016
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events

$44.5Mvaluation at IPOFeb 2021 · $0.62/share · 424B4

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Competitors · 3

by search overlap

Inspire Medical16 shared keywordsInspire Medical Systems develops an FDA-approved implantable device that treats obstructive sleep apnea (OSA) by working with the patient's natural breathing, controlled via a small remote and intended for patients for whom CPAP is not effective. The device is surgically placed by an ENT and configured by a sleep medicine professional.

Simply Wall St13 shared keywordsSimply Wall St is an investment platform that provides financial data visualization and analysis tools for individual investors. The platform serves long-term investors globally by simplifying complex market information into visual and narrative formats to make stock investing more accessible.

Quiverquant12 shared keywordsQuiver Quantitative scrapes and aggregates alternative stock market data from across the internet into a free web dashboard. It targets retail investors, giving non-professional traders access to alternative data typically reserved for institutional money managers.

Companies competing with InspireMD for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does InspireMD do?: InspireMD develops and commercializes medical devices for vascular intervention, including carotid stent systems and embolic protection systems sold through direct sales in the United States and via distributors in international markets.
Who are InspireMD's investors?: InspireMD's investors include OrbiMed.
How much funding has InspireMD raised?: InspireMD has disclosed $83.8M raised across 5 of its 6 known rounds.
Where is InspireMD headquartered?: InspireMD is headquartered in Miami, US.